Hims & Hers Health Inc
HIMS
ISIN null / Valor 59397181
Hims & Hers Health Inc
UMushroom community rating:
About company
Hims & Hers Health Inc. operates as a telehealth company that provides a broad range of health and wellness services through a fully online platform. The company, which boasts over 1 million subscribers, facilitates access to licensed healthcare professionals across all 50 states, including physicians, nurse practitioners, psychiatrists, dermatologists, and pharmacists. These professionals offer evidence-based treatment and care in various domains such as sexual health, skincare, mental health, and hair care. By leveraging technology, Hims & Hers Health Inc. aims to streamline the healthcare process, making it more accessible and convenient for patients to receive care. The company's model represents a shift towards more digital, patient-centered healthcare solutions, addressing key wellness areas through its online services.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (18.11.2025):
In Q3 2025, Hims & Hers Health Inc delivered strong financial performance with robust revenue growth, improved adjusted EBITDA, and significant subscriber expansion. The company’s results showed a 49% year-over-year increase in revenue to nearly $600 million, alongside operational improvements and solid margin management, underscoring its strategy to expand access to personalized health and wellness care.
Revenue Growth
Hims & Hers Health Inc reported total revenue of approximately $599 million in Q3 2025, marking a 49% increase compared to Q3 2024. This performance was driven by notable growth in online revenue, which contributed significantly to the overall revenue boost.
Profitability and EBITDA Improvement
Despite a lower gross margin of 74% compared to 79% in Q3 2024, the net income reached nearly $16 million, and Adjusted EBITDA increased to over $78 million, reflecting a strengthening operational performance and effective cost management.
Subscriber and Engagement Expansion
The subscriber base grew to almost 2.5 million, a 21% increase year-over-year, and the monthly online revenue per average subscriber rose by 19%, underscoring growing customer engagement and the platform's incremental monetization success.
Financial Guidance
Looking ahead, Hims & Hers Health Inc provided clear guidance for the remainder of 2025 with Q4 revenue expectations between $605 million and $625 million, and full year revenue guidance of $2.335 billion to $2.355 billion. Adjusted EBITDA guidance for Q4 is projected to be between $55 million and $65 million while full year expectations range from $307 million to $317 million.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
7951 M
Market cap (USD)
26,537,262
Daily traded volume (Shares)
26.12 / 25.01
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
James Sukkhamfong
Hisham Noor
Rohan Joseph
EQUITIES OF THE SAME SECTOR
